← Leaderboards
Angela H Ting
Cleveland Clinic Lerner Com-Cwru
$5,070,113
Attributed
$7,364,416
Total exposure
4
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.2M · FY2011–25$2M$1.5M$1M$500K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$7,364,416 · 4
By mechanism
R01$4,949,416 · 3
U01$2,415,000 · 1
Top collaborators
- Byron H Lee5 shared
- Oliver Wessely5 shared
- Christopher D Johnston2 shared
Most similar at Cleveland Clinic Lerner Com-Cwru
Same institution · by research overlap
- Emilio Daniel Poggio$3,940,852
- Mona Doshi$1,185,873
- Oliver Wessely$11,220,325
- Emily E Fink$91,888
- Anna Valujskikh$13,893,856
Others in their field
Top investigators on “Prevent”
- Lawrence Corey · Fred Hutchinson Cancer Center$609,181,782
- Jeffrey P Krischer · University Of South Florida$605,511,231
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$530,065,238
- Bambra Strokes · Ppd Development Lp$526,656,217
- Judith S. Currier · University Of California Los Angeles$499,311,118
- David Heimbrook · Leidos Biomedical Research, Inc.$496,394,926
Research focus
PreventCellsAffectSiteMolecularMapsGene ExpressionPhysiologicalTranscriptomeMalignant NeoplasmsGenesHypermethylationDna MethylationDna Modification ProcessMethylationBaseTissuesGenomicsProtein IsoformsTranscription FactorPathologicMessenger RnaCostBinding Sites
Grant awards (17)
Interrogating the Role of Bacterial Methyl-modifying Enzymes in Pathoadaptation and Host Epigenetic Interference in Cancer$676,366
R01 · FY2025 · CA
High resolution transcriptome and gene regulatory mapping of human ureter and bladder across the lifespan$483,000
U01 · FY2025 · DK
Interrogating the Role of Bacterial Methyl-modifying Enzymes in Pathoadaptation and Host Epigenetic Interference in Cancer$692,241
R01 · FY2024 · CA
High resolution transcriptome and gene regulatory mapping of human ureter and bladder across the lifespan$483,000
U01 · FY2024 · DK
High resolution transcriptome and gene regulatory mapping of human ureter and bladder across the lifespan$483,000
U01 · FY2023 · DK
Understanding the full spectrum of epigenetic vulnerability in cancer through the delineation of DNA methylation function in gene 3' end$392,412
R01 · FY2023 · CA · contact PI
High resolution transcriptome and gene regulatory mapping of human ureter and bladder across the lifespan$483,000
U01 · FY2022 · DK
Understanding the full spectrum of epigenetic vulnerability in cancer through the delineation of DNA methylation function in gene 3' end$389,313
R01 · FY2022 · CA · contact PI
High resolution transcriptome and gene regulatory mapping of human ureter and bladder across the lifespan$483,000
U01 · FY2021 · DK
Understanding the full spectrum of epigenetic vulnerability in cancer through the delineation of DNA methylation function in gene 3' end$401,019
R01 · FY2021 · CA · contact PI
Understanding the full spectrum of epigenetic vulnerability in cancer through the delineation of DNA methylation function in gene 3' end$399,981
R01 · FY2020 · CA · contact PI
Understanding the full spectrum of epigenetic vulnerability in cancer through the delineation of DNA methylation function in gene 3' end$398,528
R01 · FY2019 · CA · contact PI
Characterizing the DNA methylomes of indolent and aggressive prostate cancers$325,775
R01 · FY2015 · CA · contact PI
Characterizing the DNA methylomes of indolent and aggressive prostate cancers$316,002
R01 · FY2014 · CA · contact PI
Characterizing the DNA methylomes of indolent and aggressive prostate cancers$306,229
R01 · FY2013 · CA · contact PI
Characterizing the DNA methylomes of indolent and aggressive prostate cancers$325,775
R01 · FY2012 · CA · contact PI
Characterizing the DNA methylomes of indolent and aggressive prostate cancers$325,775
R01 · FY2011 · CA · contact PI